Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Felix KRENZIEN"'
Autor:
Nathanael Raschzok, Simon Moosburner, Moritz Blank, Felix Krenzien, Georg Lurje, Wenzel Schöning, Igor M. Sauer, Johann Pratschke, Dominik P. Modest, Annika Kurreck
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Multimodal two-stage hepatectomy (mTSH) is used in patients with bilobar colorectal liver metastases (CRLM) that cannot be treated with one surgical procedure due to insufficient future liver remnant. Interval chemotherapy has bee
Externí odkaz:
https://doaj.org/article/9c2f0350e7de4f1788ca33b29e4f6797
Autor:
Can Kamali, Philipp Brunnbauer, Kaan Kamali, Al-Hussein Ahmed Saqr, Alexander Arnold, Gulcin Harman Kamali, Julia Babigian, Eriselda Keshi, Raphael Mohr, Matthäus Felsenstein, Simon Moosburner, Karl-Herbert Hillebrandt, Jasmin Bartels, Igor Maximilian Sauer, Frank Tacke, Moritz Schmelzle, Johann Pratschke, Felix Krenzien
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-13 (2024)
Abstract Liver fibrosis progressing to cirrhosis is a major risk factor for liver cancer, impacting surgical treatment and survival. Our study focuses on the role of extracellular nicotinamide adenine dinucleotide (eNAD+) in liver fibrosis, analyzing
Externí odkaz:
https://doaj.org/article/ac5cefb1237e4ca48bf1eab5058ca5bd
Autor:
Lisa-Marie Skrip, Simon Moosburner, Peter Tang, Jing Guo, Steffen Görner, Heiko Tzschätzsch, Kristin Brüggemann, Kilian Alexander Walter, Clarissa Hosse, Uli Fehrenbach, Alexander Arnold, Dominik Modest, Felix Krenzien, Wenzel Schöning, Thomas Malinka, Johann Pratschke, Björn Papke, Josef A. Käs, Ingolf Sack, Igor M. Sauer, Karl H. Hillebrandt
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Colorectal cancer is the third most common tumour entity in the world and up to 50% of the patients develop liver metastases (CRLM) within five years. To improve and personalize therapeutic strategies, new diagnostic tools are urg
Externí odkaz:
https://doaj.org/article/4d8a063d200f4829a702332450f30823
Autor:
Maximilian Zimmer, Karl Herbert Hillebrandt, Nathalie Nora Roschke, Steffen Lippert, Oliver Klein, Grit Nebrich, Joseph Maria George Vernon Gassner, Felix Strobl, Johann Pratschke, Felix Krenzien, Igor Maximilian Sauer, Nathanael Raschzok, Simon Moosburner
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-14 (2024)
Abstract Background Liver grafts are frequently declined due to high donor age or age mismatch with the recipient. To improve the outcome of marginal grafts, we aimed to characterize the performance of elderly vs. young liver grafts in a standardized
Externí odkaz:
https://doaj.org/article/97915733214b4c90b2a9ed1e285a1b80
Autor:
Isis Lozzi, Alexander Arnold, Matthias Barone, Juliette Claire Johnson, Bruno V Sinn, Johannes Eschrich, Pimrapat Gebert, Ruonan Wang, Mengwen Hu, Linda Feldbrügge, Anja Schirmeier, Anja Reutzel-Selke, Thomas Malinka, Felix Krenzien, Wenzel Schöning, Dominik P Modest, Johann Pratschke, Igor M Sauer, Matthäus Felsenstein
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Background Intrahepatic cholangiocarcinoma (ICC) is a disease with poor prognosis and limited therapeutic options. We investigated the tumor immune microenvironment (TIME) to identify predictors of disease outcome and to explore targets for therapeut
Externí odkaz:
https://doaj.org/article/e0446c6ce3f8424696faa2dce6d8a997
Autor:
Johannes Kolck, Clarissa Hosse, Nick Lasse Beetz, Timo Alexander Auer, Adrian Alexander Marth, Laura Segger, Felix Krenzien, Georg Lurje, Uwe Pelzer, Dominik Geisel, Wenzel Schöning, Uli Fehrenbach
Publikováno v:
Cancer Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
Abstract Background and Aims Intrahepatic cholangiocarcinoma (iCC) is an aggressive tumor, usually detected at an advanced stage. Our aim was to investigate the potential of body composition analysis (BCA) derived from presurgical staging computed to
Externí odkaz:
https://doaj.org/article/347d83ee19e8425bbc74bf7c24d30faf
Autor:
Sebastian Knitter, Linda Sauer, Karl-H. Hillebrandt, Simon Moosburner, Uli Fehrenbach, Timo A. Auer, Nathanael Raschzok, Georg Lurje, Felix Krenzien, Johann Pratschke, Wenzel Schöning
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1145-1161 (2024)
Background: Two-staged hepatectomy (TSH) including portal vein embolization (PVE) may offer surgical treatment for extensive bilobar colorectal liver metastases (CRLM). This study aimed to investigate the feasibility and outcomes of extended right he
Externí odkaz:
https://doaj.org/article/8ee806cf79e44c5da11a61bc43039017
Autor:
Nathanael Raschzok, Simon Moosburner, Moritz Blank, Felix Krenzien, Georg Lurje, Wenzel Schöning, Igor M. Sauer, Johann Pratschke, Dominik P. Modest, Annika Kurreck
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/3446e2ac461442b9a31dd83956360f26
Autor:
Sharlyn S. T. Ng, Robert Oehring, Nikitha Ramasetti, Roland Roller, Philippe Thomas, Yuxuan Chen, Simon Moosburner, Axel Winter, Max-Magnus Maurer, Timo A. Auer, Can Kamali, Johann Pratschke, Christian Benzing, Felix Krenzien
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Introduction Multidisciplinary team meetings (MDMs), also known as tumor conferences, are a cornerstone of cancer treatments. However, barriers such as incomplete patient information or logistical challenges can postpone tumor board decision
Externí odkaz:
https://doaj.org/article/1fefc87117a5489b8de3cbb4072da770
Autor:
Al-Hussein Ahmed Saqr, Can Kamali, Philipp Brunnbauer, Nils Haep, Pia Koch, Karl-Herbert Hillebrandt, Eriselda Keshi, Simon Moosburner, Raphael Mohr, Nathanael Raschzok, Johann Pratschke, Felix Krenzien
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
Nicotinamide adenine dinucleotide (NAD+), a coenzyme for more than 500 enzymes, plays a central role in energy production, metabolism, cellular signaling, and DNA repair. Until recently, NAD+ was primarily considered to be an intracellular molecule (
Externí odkaz:
https://doaj.org/article/f62e9aee36234b028fc99e7ac63e2fbb